0001209191-19-044045.txt : 20190801
0001209191-19-044045.hdr.sgml : 20190801
20190801165841
ACCESSION NUMBER: 0001209191-19-044045
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190610
FILED AS OF DATE: 20190801
DATE AS OF CHANGE: 20190801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bernstein Karen
CENTRAL INDEX KEY: 0001654055
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 19993400
MAIL ADDRESS:
STREET 1: C/O VITAE PHARMACEUTICLS, INC.
STREET 2: 502 WEST OFFICE CENTER DRIVE
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-06-10
2019-06-10
0
0001636651
Ovid Therapeutics Inc.
OVID
0001654055
Bernstein Karen
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
1
0
0
0
Stock Option (Right to Buy)
1.65
2019-06-10
4
A
0
5813
0.00
A
2029-06-09
Common Stock
5813
5813
D
This Amended Form 4 is being filed to correct inaccuracies with respect to the transaction date and exercise price of the stock options and reported in Table II of the Form 4 filed on June 10, 2019.
The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date.
Danielle Mann for Karen Bernstein by POA
2019-07-31